Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omada Health Inc (OMDA)

Omada Health Inc (OMDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The 2026 Healthcare Reset: Subscription Economics Meets MRI-Grade AI Precision

Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER – Baystreet.ca News Commentary – The medical imaging market is pivoting toward strict economic accountability. AI cardiac platforms...

LFMD : 3.07 (-3.46%)
TDOC : 4.91 (-3.91%)
VPT.VN : 0.120 (unch)
HIMS : 24.40 (-4.46%)
VPTDF : 0.0890 (+6.08%)
OMDA : 13.51 (+2.50%)
Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025

SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced preliminary, unaudited revenue for the fourth quarter and...

OMDA : 13.51 (+2.50%)
Omada Health’s GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss

SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis...

OMDA : 13.51 (+2.50%)
Omada Health to Participate in J.P. Morgan Healthcare Conference

SAN FRANCISCO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in...

OMDA : 13.51 (+2.50%)
Omada Health to Participate in Evercore Healthcare Conference

SAN FRANCISCO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in...

OMDA : 13.51 (+2.50%)
Omada Health Announces GLP-1 Prescribing Capability to Support Growing Member Population

SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced the planned launch of its prescribing capability....

OMDA : 13.51 (+2.50%)
Omada Health Reports Third Quarter 2025 Results

Revenue of $ 68 million, up 49% ; 53% Member Growth Significant Reduction in Net Loss and First Quarter of Positive Adjusted EBITDA Announces New GLP-1 Prescribing Offering SAN FRANCISCO,...

OMDA : 13.51 (+2.50%)
Omada Health Welcomes Thomas Tsang, MD, MPH as Chief Medical Officer

SAN FRANCISCO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced the appointment of Thomas Tsang, MD, MPH as Chief Medical...

OMDA : 13.51 (+2.50%)
Omada Health to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025

SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2025 results on...

OMDA : 13.51 (+2.50%)
Omada Health added to ‘Tactical Outperform’ list at Evercore ISI

Evercore ISI analyst Elizabeth Anderson added Omada Health (OMDA) to the firm’s “Tactical Outperform” list as the firm updates estimates and makes several tactical calls in the Healthcare Technology...

OMDA : 13.51 (+2.50%)

Barchart Exclusives

This Dividend Stock Reports Q4 Earnings on February 20. Is It a Buy, Sell, or Hold?
AngloGold Ashanti will release its Q4 earnings later this month, where it is expected to announce an additional dividend along with the regular dividend of 12.5 cents. Is the stock a buy ahead of the report? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar